Zinc-Excess Intake Causes the Deterioration of Renal Function Accompanied by an Elevation in Systemic Blood Pressure Primarily Through Superoxide Radical-Induced Oxidative Stress

Int J Toxicol. 2014 Jul;33(4):288-296. doi: 10.1177/1091581814532958. Epub 2014 May 7.

Abstract

Using rats fed 22 g/d of a control diet containing 0.005% zinc (Zn) or 2 Zn-excess diets containing 0.05% or 0.2% Zn for 4 weeks, we examined the mechanisms involved in the deterioration of renal function induced by Zn-excess intake. An increase in Zn intake elevated mean blood pressure (BP) and reduced renal blood flow (RBF) and inulin clearance in a dose-dependent manner. This decline in inulin clearance may be derived from a fall in RBF. Administration of the nitric oxide (NO) synthase inhibitor, Nω-nitro-l-arginine methyl ester, markedly increased mean BP and significantly decreased RBF in the 3 groups of rats. Administration of the exogenous superoxide radical (OO-) scavenger, tempol, significantly decreased mean BP and substantially increased RBF in all groups of rats. These observations suggest that both an elevation in systemic BP and a reduction in RBF seen in the 2 Zn-excess diet groups result from a decrease in the action of the vasodilator, NO, through the formation of peroxynitrite based on the nonenzymatic reaction of NO and increased OO- Indeed, the activity of the endogenous OO- scavenger, copper/Zn-superoxide dismutase, was significantly reduced in the vessel wall of rats fed 2 Zn-excess diets versus a control diet. 8-Hydroxy-2'-deoxyguanosine formation caused by OO- generation was notably elevated in the kidneys of rats fed 2 Zn-excess diets relatively to rats fed a control diet. Thus, Zn-excess intake leads to the aggravation of renal function concomitantly with an increase in systemic BP predominantly through the oxidative stress caused by OO<sup/>.

Keywords: blood pressure; oxidative stress; renal function; zinc.

Publication types

  • Comparative Study

MeSH terms

  • 8-Hydroxy-2'-Deoxyguanosine
  • Animals
  • Aorta, Thoracic
  • Biomarkers / blood
  • Biomarkers / metabolism
  • Biomarkers / urine
  • Deoxyguanosine / analogs & derivatives
  • Deoxyguanosine / metabolism
  • Dietary Supplements / poisoning*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiopathology
  • Enzyme Inhibitors / adverse effects
  • Free Radical Scavengers / therapeutic use
  • Heavy Metal Poisoning / drug therapy
  • Heavy Metal Poisoning / metabolism
  • Heavy Metal Poisoning / pathology
  • Heavy Metal Poisoning / physiopathology*
  • Hypertension, Renovascular / etiology*
  • Hypertension, Renovascular / physiopathology
  • Hypertension, Renovascular / prevention & control
  • Inulin / blood
  • Inulin / pharmacokinetics
  • Inulin / urine
  • Kidney / blood supply
  • Kidney / drug effects
  • Kidney / pathology
  • Kidney / physiopathology*
  • Male
  • Metabolic Clearance Rate / drug effects
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism
  • Oxidative Stress* / drug effects
  • Random Allocation
  • Rats, Sprague-Dawley
  • Renal Insufficiency / etiology*
  • Renal Insufficiency / physiopathology
  • Renal Insufficiency / prevention & control
  • Superoxide Dismutase-1 / antagonists & inhibitors
  • Superoxide Dismutase-1 / metabolism
  • Zinc / poisoning*

Substances

  • Biomarkers
  • Enzyme Inhibitors
  • Free Radical Scavengers
  • 8-Hydroxy-2'-Deoxyguanosine
  • Inulin
  • Nitric Oxide Synthase
  • Sod1 protein, rat
  • Superoxide Dismutase-1
  • Deoxyguanosine
  • Zinc